GILEAD SCIENCES INC

Gilead Sciences’ latest trading move shows a modest pullback around its 200‑day SMA, while investors eye earnings, regulatory shifts, and sector peers for the next growth push.

Gilead Sciences stock rises 2.36% to $156.04, trading 976 M USD in 24 h. Explore its market cap, 52‑week range and biopharma focus on HIV and liver disease.